PTK2 and Hepatic fibrosis: Importantly, pharmacologic inhibition of FAK attenuates liver fibrosis in vivo in a mouse model of liver fibrosis, suggesting that targeting FAK mediated signaling is likely to attenuate the progression of liver fibrosis.